Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter Randomized Clinical Trial to Assess the Advantages of Robotic Total Mesorectal Excision in Preserving External Sphincter in Patients with Middle and Low Rectal Cancer.

NCT06105203 is registered in ClinicalTrials.gov with The First Hospital of Jilin University as lead sponsor.

NCT NCT06105203
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06105203 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter Randomized Clinical Trial to Assess the Advantages of Robotic Total Mesorectal Excision in Preserving External Sphincter in Patients with Middle and Low Rectal Cancer.
Lead sponsor
The First Hospital of Jilin University
Phase
Not applicable
Overall status
Not yet recruiting
Start date
November 1, 2025
Completion date
January 31, 2031
Enrollment
1,026 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

laparoscopy, rectal neoplasms, robotic surgical procedures, total mesorectal excision